R. M. CHERNIACK, M.D., F.R.C.P.(C), F.A.C.P.; G. YOUNG, M.D.
The role of respiratory stimulants in the management of acute respiratory failure due to barbiturate intoxication or chronic respiratory failure due to pulmonary disease is a subject of considerable debate. While some investigators claim that analeptics are of little use in the management of barbiturate intoxication (1), others have recently stated that ethamivan (Emivan®), a central nervous system stimulant, is valuable (2-4). Similarly, it has been reported to be beneficial in chronic respiratory failure by some authors (5, 6), while less impressive results have also been reported (7).
This paper presents an attempt to evaluate the effect of ethamivan in
Learn more about subscription options.
Register Now for a free account.
CHERNIACK RM, YOUNG G. An Evaluation of Ethamivan as a Respiratory Stimulant in Barbiturate Intoxication, and Alveolar Hypoventilation in Emphysema and Obesity. Ann Intern Med. 1964;60:631–640. doi: 10.7326/0003-4819-60-4-631
Download citation file:
Published: Ann Intern Med. 1964;60(4):631-640.
Obesity, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only